Warren Buffett Just Invested $3.9 Billion in 12 Stocks. Here's the Best of the Bunch.

Despite being a net seller for the 11th consecutive quarter, Warren Buffett's Berkshire Hathaway deployed $3.9 billion into 12 stocks during Q2 2025, initiating three new positions. Notably, the largest allocation, $1.57 billion, went to UnitedHealth Group (UNH), cited for its attractive PEG ratio and resilient business despite ongoing challenges like higher medical costs and a Department of Justice probe. Other significant activity included increased stakes in Chevron and Lennar, and new positions in Allegion and Lamar Advertising, reflecting a diversified investment strategy and Buffett's continued focus on value and growth opportunities.

Analysis

Despite Berkshire Hathaway being a net seller for the 11th consecutive quarter, its Q2 2025 investment activity reveals a targeted deployment of $3.9 billion into a diverse set of companies. The most significant action was the initiation of a new, substantial $1.57 billion position in UnitedHealth Group (UNH), representing over 40% of the total capital invested. This move is underscored by UNH's attractive price-to-earnings-to-growth (PEG) ratio of 1.24, the best among the 12 stocks purchased, signaling a focus on growth at a reasonable price despite acknowledged headwinds from higher medical costs and a Department of Justice investigation. The portfolio activity also shows a continued bet on the housing sector, with new positions in D.R. Horton (DHI) and Lennar Class A (LEN) complementing an 18.4% increase in the Lennar Class B (LEN.B) stake, targeting companies with low forward price-to-earnings ratios. Furthermore, the selections cater to different investor profiles, including high-yield seekers with Lamar Advertising (LAMR) offering a 5.09% forward dividend yield, and growth investors with Nucor (NUE) and Chevron (CVX) projected to grow earnings by 32.5% and 24.4% respectively.

Key Decisions for Investors

• Investors should evaluate UnitedHealth Group (UNH) as a potential core holding, given its status as Berkshire's largest Q2 purchase and its attractive PEG ratio of 1.24, while remaining cognizant of the risks associated with rising medical costs and the ongoing DOJ probe.
• Consider mimicking Berkshire's thematic diversification by analyzing value opportunities in homebuilders like D.R. Horton (DHI) and Lennar (LEN), high-yield income from Lamar Advertising (LAMR) with its 5.09% forward yield, and strong earnings growth potential from Nucor (NUE).
• For those prioritizing income and growth within the energy sector, Chevron (CVX) warrants attention due to Berkshire's increased stake, a robust 4.39% dividend yield, and a projected earnings growth of 24.4%.
• Note the strong institutional support for Constellation Brands (STZ), which has a consensus analyst price target implying a 22% upside, suggesting it may offer a compelling risk-reward profile for growth-oriented investors.